---
title: "Pre-market hot trades in US stocks: UnitedHealth up 5.73% pre-market; Passage Bio up 5.60% pre-market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283475504.md"
description: "UnitedHealth pre-market up 5.73%; Passage Bio pre-market up 5.60%; Local Bounti pre-market up 61.70%; Baiya pre-market up 55.73%; SciSparc pre-market up 53.59%"
datetime: "2026-04-21T10:03:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283475504.md)
  - [en](https://longbridge.com/en/news/283475504.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283475504.md)
---

# Pre-market hot trades in US stocks: UnitedHealth up 5.73% pre-market; Passage Bio up 5.60% pre-market

**Pre-market Hot Trades in US Stocks**

UnitedHealth is up 5.73% in pre-market trading. Based on recent key news:

1.  On April 21, UnitedHealth announced its first-quarter earnings report, with revenue of $111.7 billion, exceeding market expectations of $109.57 billion, and adjusted earnings per share of $7.23, compared to market expectations of $6.57. This performance exceeded expectations and drove the stock price up. Source: Reuters
    
2.  On April 21, UnitedHealth announced it would repurchase at least $2 billion of common stock before the end of the second quarter to enhance market confidence, resulting in a rise in stock price. Source: Reuters
    
3.  On April 20, analysts expect UnitedHealth to deliver robust performance with manageable medical cost trends, driving the stock price up. Source: Morgan Stanley analyst report indicates that medical cost pressures remain, and risks need to be monitored.
    

Passage Bio is up 5.60% in pre-market trading. Based on recent key news:

1.  On April 20, Passage Bio announced that its experimental gene therapy PBFT02 showed signs of slowing disease progression in patients with rare hereditary frontotemporal dementia. This news drove the stock price up by 8.6%. Source: Reuters
    
2.  On April 20, the FDA indicated in a Type C meeting that it does not support a single-arm trial design and requires a randomized controlled trial for registration approval. This news caused stock price fluctuations. Source: CNBC
    
3.  On April 20, the company began reviewing strategic options, including potential sale, merger, or collaboration, hiring Wedbush PacGrow as an advisor. This move aims to maximize shareholder value. Source: Bloomberg The biotechnology sector has been active recently, with significant capital inflows.
    

**Top Gainers in Pre-market US Stocks**

Local Bounti is up 61.70% in pre-market trading, with no significant recent news. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and specific reasons need further observation.

Baiya is up 55.73% in pre-market trading, with no significant recent news. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and specific reasons need further observation.

SciSparc is up 53.59% in pre-market trading, with no significant recent news. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and specific reasons need further observation

### Related Stocks

- [UNH.US](https://longbridge.com/en/quote/UNH.US.md)
- [PASG.US](https://longbridge.com/en/quote/PASG.US.md)

## Related News & Research

- [Stephens Inc. AR Purchases 9,617 Shares of UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/286668330.md)
- [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md)
- [Greg Abel Sells Berkshire Hathaway Stake in UnitedHealth Triggering Stock Slide. Bet on UNH Here for a Turnaround.](https://longbridge.com/en/news/287110587.md)
- [Zacks Research Issues Optimistic Estimate for UNH Earnings](https://longbridge.com/en/news/286908689.md)
- [Berkshire's UnitedHealth exit sends shares lower despite turnaround](https://longbridge.com/en/news/286859237.md)